These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 33672611)

  • 41. The double-edged sword of inflammation in inherited retinal degenerations: Clinical and preclinical evidence for mechanistically and prognostically impactful but treatable complications.
    Sarici K; Vyas A; Iannaccone A
    Front Cell Dev Biol; 2023; 11():1177711. PubMed ID: 37123408
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HIF-1α stabilization reduces retinal degeneration in a mouse model of retinitis pigmentosa.
    Olivares-González L; Martínez-Fernández de la Cámara C; Hervás D; Millán JM; Rodrigo R
    FASEB J; 2018 May; 32(5):2438-2451. PubMed ID: 29295858
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Necroptosis in microglia contributes to neuroinflammation and retinal degeneration through TLR4 activation.
    Huang Z; Zhou T; Sun X; Zheng Y; Cheng B; Li M; Liu X; He C
    Cell Death Differ; 2018 Jan; 25(1):180-189. PubMed ID: 28885615
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunology of Retinitis Pigmentosa and Gene Therapy-Associated Uveitis.
    Yang P; Mustafi D; Pepple KL
    Cold Spring Harb Perspect Med; 2024 Jan; 14(1):. PubMed ID: 37037600
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Role of Microglia in Inherited Retinal Diseases.
    Kumari A; Borooah S
    Adv Exp Med Biol; 2023; 1415():197-205. PubMed ID: 37440034
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Constitutive overexpression of human erythropoietin protects the mouse retina against induced but not inherited retinal degeneration.
    Grimm C; Wenzel A; Stanescu D; Samardzija M; Hotop S; Groszer M; Naash M; Gassmann M; Remé C
    J Neurosci; 2004 Jun; 24(25):5651-8. PubMed ID: 15215287
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Approach to inherited retinal diseases.
    Ratra D; Ozdek S; Raviselvan M; Elchuri S; Sharma T
    Indian J Ophthalmol; 2022 Jul; 70(7):2305-2315. PubMed ID: 35791111
    [TBL] [Abstract][Full Text] [Related]  

  • 48. RNA-based therapies in inherited retinal diseases.
    Girach A; Audo I; Birch DG; Huckfeldt RM; Lam BL; Leroy BP; Michaelides M; Russell SR; Sallum JMF; Stingl K; Tsang SH; Yang P
    Ther Adv Ophthalmol; 2022; 14():25158414221134602. PubMed ID: 36388727
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Emerging Drug Therapies for Inherited Retinal Dystrophies.
    Sundaramurthi H; Moran A; Perpetuini AC; Reynolds A; Kennedy B
    Adv Exp Med Biol; 2019; 1185():263-267. PubMed ID: 31884622
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Role of Ceramide in Inherited Retinal Disease Pathology.
    Qian X; Srinivasan T; He J; Chen R
    Adv Exp Med Biol; 2023; 1415():303-307. PubMed ID: 37440049
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Photoreceptor cell death mechanisms in inherited retinal degeneration.
    Sancho-Pelluz J; Arango-Gonzalez B; Kustermann S; Romero FJ; van Veen T; Zrenner E; Ekström P; Paquet-Durand F
    Mol Neurobiol; 2008 Dec; 38(3):253-69. PubMed ID: 18982459
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Systemic diseases associated with retinal dystrophies.
    Werdich XQ; Place EM; Pierce EA
    Semin Ophthalmol; 2014; 29(5-6):319-28. PubMed ID: 25325857
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cellular and molecular alterations in neurons and glial cells in inherited retinal degeneration.
    Martínez-Gil N; Maneu V; Kutsyr O; Fernández-Sánchez L; Sánchez-Sáez X; Sánchez-Castillo C; Campello L; Lax P; Pinilla I; Cuenca N
    Front Neuroanat; 2022; 16():984052. PubMed ID: 36225228
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Descriptive Study of a Cohort of 488 Patients with Inherited Retinal Dystrophies.
    Coco-Martin RM; Diego-Alonso M; Orduz-Montaña WA; Sanabria MR; Sanchez-Tocino H
    Clin Ophthalmol; 2021; 15():1075-1084. PubMed ID: 33727790
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A pilot investigation of audiovisual processing and multisensory integration in patients with inherited retinal dystrophies.
    Myers MH; Iannaccone A; Bidelman GM
    BMC Ophthalmol; 2017 Dec; 17(1):240. PubMed ID: 29212538
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Developing Cell-Based Therapies for RPE-Associated Degenerative Eye Diseases.
    Ben M'Barek K; Habeler W; Regent F; Monville C
    Adv Exp Med Biol; 2019; 1186():55-97. PubMed ID: 31654386
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genome Editing as a Treatment for the Most Prevalent Causative Genes of Autosomal Dominant Retinitis Pigmentosa.
    Diakatou M; Manes G; Bocquet B; Meunier I; Kalatzis V
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31126147
    [No Abstract]   [Full Text] [Related]  

  • 58. Alterations to retinal architecture prior to photoreceptor loss in a mouse model of retinitis pigmentosa.
    Roche SL; Wyse-Jackson AC; Byrne AM; Ruiz-Lopez AM; Cotter TG
    Int J Dev Biol; 2016; 60(4-6):127-39. PubMed ID: 27160072
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Microglia-Müller glia crosstalk in the rd10 mouse model of retinitis pigmentosa.
    Arroba AI; Alvarez-Lindo N; van Rooijen N; de la Rosa EJ
    Adv Exp Med Biol; 2014; 801():373-9. PubMed ID: 24664720
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Retinitis Pigmentosa and Other Dystrophies.
    Mrejen S; Audo I; Bonnel S; Sahel JA
    Dev Ophthalmol; 2017; 58():191-201. PubMed ID: 28351048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.